Vitamin K antagonists and emergencies.

Area of Science:

• Pharmacology
• Emergency Medicine
• Hematology

Background:

• Vitamin K antagonists (VKA) remain globally prevalent oral anticoagulants despite newer alternatives.
• VKAs are indicated in specific patient populations like the elderly or those with severe comorbidities.
• Understanding VKA pharmacology is crucial for safe and effective patient management.

Purpose of the Study:

• To provide emergency physicians with a comprehensive 10-point summary on managing patients on VKAs.
• To outline pharmacological data and emergency management strategies for VKA therapy.
• To address challenges in VKA treatment, including induction, overdose, and bleeding complications.

Main Methods:

• Review of existing literature on Vitamin K antagonist pharmacology and clinical use.
• Development of a structured approach for emergency physicians managing VKA patients.
• Integration of international normalized ratio (INR) monitoring and vitamin K administration protocols.

Main Results:

• VKA therapy requires a 5-day induction period for stable anticoagulation.
• The induction phase carries the highest bleeding risk, necessitating validated INR-based algorithms.
• Management strategies include dose adjustment, vitamin K administration, and prothrombin complex concentrate for reversal.

Conclusions:

• A codified strategy is essential for managing VKA-related bleeding complications and pre-procedure INR normalization.
• Prothrombin complex concentrate with vitamin K is effective for rapid VKA reversal.
• Emergency physicians must be proficient in VKA management for optimal patient outcomes.